Cytrx Corp (NASDAQ:CYTR)
CAPS Rating:
A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.
RSS Headlines
Fool UK
Recs
This company has money in the bank out the wazoo and 0 debt. How can anyone not see that there has to be growth there?